register

Human Resources

Dr Evans shares insights on how leaders can liberate team talent

Health Industry Hub | December 9, 2019 |

The world of work is changing faster than ever before. Huge technological, structural and demographic shifts mean that in order to remain competitive, our organisations must start to better leverage the skills and expertise of their employees.

In this podcast Hays is joined by Dr Maggi Evans, Director of Mosaic Consulting and co-author of from Talent Management to Talent Liberation.

Maggi talks about how leaders can start to make the shift from simply managing the talent within our organisations, to liberating it.

You may also like Happy employees are more productive, research shows

Looking for talent? Post a job to reach Australian Pharma, MedTech and Biotech industry professionals. High reach. Engaged audience. Competitive pricing. Contact us.


News & Trends - MedTech & Diagnostics

Health insurers clash with government decision on GUIs, prompting threat of premium hikes

Health insurers clash with government on GUIs decision, prompting threat of premium hikes

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A warning of potential increases in health insurance premiums for 15 million Australians has been issued […]

More


News & Trends - MedTech & Diagnostics

Catheter ablation underused in atrial fibrillation despite proven efficacy

Catheter ablation underused in atrial fibrillation despite proven efficacy

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A new study highlights that nearly half of all patients hospitalised for atrial fibrillation (AF) in […]

More


News & Trends - Biotechnology

How prepared are we for the next pandemic?

How prepared are we for the next pandemic?

Health Industry Hub | May 2, 2024 |

Biotech News: The Melbourne biotechnology community came together for a symposium hosted by BioMelbourne and mRNA Victoria, featuring specialists in […]

More


News & Trends - Pharmaceuticals

AbbVie's JAK inhibitor triumphs: Head-to-Head trial reveals superior outcomes in atopic dermatitis

AbbVie’s JAK inhibitor triumphs: Head-to-Head trial reveals superior outcomes in atopic dermatitis

Health Industry Hub | May 2, 2024 |

Pharma News: In a head-to-head trial, AbbVie’s JAK inhibitor Rinvoq (upadacitinib) showed superior efficacy over Regeneron and Sanofi’s Dupixent (dupilumab) […]

More


This content is copyright protected. Please subscribe to gain access.